Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress
Background & aims: Ageing is associated with an increased risk of frailty, intestinal microbiota perturbations, immunosenescence and oxidative stress. Prebiotics such as galacto-oligosaccharides (GOS) may ameliorate these ageing-related alterations. We aimed to compare the faecal microbiota composition, metabolite production, immune and oxidative stress markers in prefrail elderly and younger adults, and investigate the effects of GOS supplementation in both groups. Methods: In a randomised controlled cross-over study, 20 prefrail elderly and 24 healthy adults received 21.6 g/day Biotis™ GOS (containing 15.0 g/day GOS) or placebo. Faecal 16S rRNA gene-based microbiota and short-chain fatty acids were analysed at 0, 1 and 4 weeks of intervention.Volatile organic compounds were analysed in breath, and stimulated cytokine production, CRP, malondialdehyde, trolox equivalent antioxidant capacity (TEAC) and uric acid (UA) in blood at 0 and 4 weeks. Results: Principle coordinate analysis showed differences in microbial composition between elderly and adults (P≤0.05), with elderly having lower bifidobacteria (P≤0.033) at baseline. In both groups, GOS affected microbiota composition (P≤0.05), accompanied by increases in bifidobacteria (P<0.001) and decreased microbial diversity (P≤0.023). Faecal and breath metabolites, immune and oxidative stress markers neither differed between groups (P ≥ 0.125) nor were affected by GOS (P ≥ 0.236). TEAC values corrected for UA were higher in elderly versus adults (P<0.001), but not different between interventions (P ≥ 0.455). Conclusions: Elderly showed lower faecal bifidobacterial (relative) abundance than adults, which increased after GOS intake in both groups. Faecal and breath metabolites, parameters of immune function and oxidative stress were not different at baseline, and not impacted by GOS supplementation. Clinicaltrials.gov with study id number: NCT03077529.
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article/Letter to editor biblioteca |
Language: | English |
Subjects: | ERP115246, Immunology, Microbiome, Nutrition, PRJEB32547, Probiotics/prebiotics, |
Online Access: | https://research.wur.nl/en/publications/galacto-oligosaccharides-supplementation-in-prefrail-older-and-he |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-wur-nl-wurpubs-578784 |
---|---|
record_format |
koha |
spelling |
dig-wur-nl-wurpubs-5787842024-10-30 Wilms, Ellen An, Ran Smolinska, Agnieszka Stevens, Yala Weseler, Antje R. Elizalde, Montserrat Drittij, Marie José Ioannou, Athanasia van Schooten, Frederik J. Smidt, Hauke Masclee, Ad A.M. Zoetendal, Erwin G. Jonkers, Daisy M.A.E. Article/Letter to editor Clinical Nutrition 40 (2021) 5 ISSN: 0261-5614 Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress 2021 Background & aims: Ageing is associated with an increased risk of frailty, intestinal microbiota perturbations, immunosenescence and oxidative stress. Prebiotics such as galacto-oligosaccharides (GOS) may ameliorate these ageing-related alterations. We aimed to compare the faecal microbiota composition, metabolite production, immune and oxidative stress markers in prefrail elderly and younger adults, and investigate the effects of GOS supplementation in both groups. Methods: In a randomised controlled cross-over study, 20 prefrail elderly and 24 healthy adults received 21.6 g/day Biotis™ GOS (containing 15.0 g/day GOS) or placebo. Faecal 16S rRNA gene-based microbiota and short-chain fatty acids were analysed at 0, 1 and 4 weeks of intervention.Volatile organic compounds were analysed in breath, and stimulated cytokine production, CRP, malondialdehyde, trolox equivalent antioxidant capacity (TEAC) and uric acid (UA) in blood at 0 and 4 weeks. Results: Principle coordinate analysis showed differences in microbial composition between elderly and adults (P≤0.05), with elderly having lower bifidobacteria (P≤0.033) at baseline. In both groups, GOS affected microbiota composition (P≤0.05), accompanied by increases in bifidobacteria (P<0.001) and decreased microbial diversity (P≤0.023). Faecal and breath metabolites, immune and oxidative stress markers neither differed between groups (P ≥ 0.125) nor were affected by GOS (P ≥ 0.236). TEAC values corrected for UA were higher in elderly versus adults (P<0.001), but not different between interventions (P ≥ 0.455). Conclusions: Elderly showed lower faecal bifidobacterial (relative) abundance than adults, which increased after GOS intake in both groups. Faecal and breath metabolites, parameters of immune function and oxidative stress were not different at baseline, and not impacted by GOS supplementation. Clinicaltrials.gov with study id number: NCT03077529. en application/pdf https://research.wur.nl/en/publications/galacto-oligosaccharides-supplementation-in-prefrail-older-and-he 10.1016/j.clnu.2020.12.034 https://edepot.wur.nl/541303 ERP115246 Immunology Microbiome Nutrition PRJEB32547 Probiotics/prebiotics https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/ Wageningen University & Research |
institution |
WUR NL |
collection |
DSpace |
country |
Países bajos |
countrycode |
NL |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-wur-nl |
tag |
biblioteca |
region |
Europa del Oeste |
libraryname |
WUR Library Netherlands |
language |
English |
topic |
ERP115246 Immunology Microbiome Nutrition PRJEB32547 Probiotics/prebiotics ERP115246 Immunology Microbiome Nutrition PRJEB32547 Probiotics/prebiotics |
spellingShingle |
ERP115246 Immunology Microbiome Nutrition PRJEB32547 Probiotics/prebiotics ERP115246 Immunology Microbiome Nutrition PRJEB32547 Probiotics/prebiotics Wilms, Ellen An, Ran Smolinska, Agnieszka Stevens, Yala Weseler, Antje R. Elizalde, Montserrat Drittij, Marie José Ioannou, Athanasia van Schooten, Frederik J. Smidt, Hauke Masclee, Ad A.M. Zoetendal, Erwin G. Jonkers, Daisy M.A.E. Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress |
description |
Background & aims: Ageing is associated with an increased risk of frailty, intestinal microbiota perturbations, immunosenescence and oxidative stress. Prebiotics such as galacto-oligosaccharides (GOS) may ameliorate these ageing-related alterations. We aimed to compare the faecal microbiota composition, metabolite production, immune and oxidative stress markers in prefrail elderly and younger adults, and investigate the effects of GOS supplementation in both groups. Methods: In a randomised controlled cross-over study, 20 prefrail elderly and 24 healthy adults received 21.6 g/day Biotis™ GOS (containing 15.0 g/day GOS) or placebo. Faecal 16S rRNA gene-based microbiota and short-chain fatty acids were analysed at 0, 1 and 4 weeks of intervention.Volatile organic compounds were analysed in breath, and stimulated cytokine production, CRP, malondialdehyde, trolox equivalent antioxidant capacity (TEAC) and uric acid (UA) in blood at 0 and 4 weeks. Results: Principle coordinate analysis showed differences in microbial composition between elderly and adults (P≤0.05), with elderly having lower bifidobacteria (P≤0.033) at baseline. In both groups, GOS affected microbiota composition (P≤0.05), accompanied by increases in bifidobacteria (P<0.001) and decreased microbial diversity (P≤0.023). Faecal and breath metabolites, immune and oxidative stress markers neither differed between groups (P ≥ 0.125) nor were affected by GOS (P ≥ 0.236). TEAC values corrected for UA were higher in elderly versus adults (P<0.001), but not different between interventions (P ≥ 0.455). Conclusions: Elderly showed lower faecal bifidobacterial (relative) abundance than adults, which increased after GOS intake in both groups. Faecal and breath metabolites, parameters of immune function and oxidative stress were not different at baseline, and not impacted by GOS supplementation. Clinicaltrials.gov with study id number: NCT03077529. |
format |
Article/Letter to editor |
topic_facet |
ERP115246 Immunology Microbiome Nutrition PRJEB32547 Probiotics/prebiotics |
author |
Wilms, Ellen An, Ran Smolinska, Agnieszka Stevens, Yala Weseler, Antje R. Elizalde, Montserrat Drittij, Marie José Ioannou, Athanasia van Schooten, Frederik J. Smidt, Hauke Masclee, Ad A.M. Zoetendal, Erwin G. Jonkers, Daisy M.A.E. |
author_facet |
Wilms, Ellen An, Ran Smolinska, Agnieszka Stevens, Yala Weseler, Antje R. Elizalde, Montserrat Drittij, Marie José Ioannou, Athanasia van Schooten, Frederik J. Smidt, Hauke Masclee, Ad A.M. Zoetendal, Erwin G. Jonkers, Daisy M.A.E. |
author_sort |
Wilms, Ellen |
title |
Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress |
title_short |
Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress |
title_full |
Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress |
title_fullStr |
Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress |
title_full_unstemmed |
Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress |
title_sort |
galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress |
url |
https://research.wur.nl/en/publications/galacto-oligosaccharides-supplementation-in-prefrail-older-and-he |
work_keys_str_mv |
AT wilmsellen galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT anran galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT smolinskaagnieszka galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT stevensyala galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT weselerantjer galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT elizaldemontserrat galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT drittijmariejose galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT ioannouathanasia galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT vanschootenfrederikj galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT smidthauke galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT mascleeadam galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT zoetendalerwing galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress AT jonkersdaisymae galactooligosaccharidessupplementationinprefrailolderandhealthyadultsincreasedfaecalbifidobacteriabutdidnotimpactimmunefunctionandoxidativestress |
_version_ |
1816154400583843840 |